Association of Bariatric Surgery Status with Reduced HER2+ Breast Cancers: a Retrospective Cohort Study
- 243 Downloads
Bariatric surgery is associated with a reduced risk of developing certain malignancies, particularly in women. However, the impact of bariatric surgery on tumor characteristics, cancer treatment, and oncologic outcomes is unknown.
In a retrospective cohort study, 42 subjects diagnosed with breast cancer after bariatric surgery (1989–2014) were matched to 84 subjects with breast cancer (1984–2012) who did not undergo bariatric surgery, based on age, body mass index (BMI), and menopausal status at the time of breast cancer diagnosis, as well as the date of cancer diagnosis. Medical records were reviewed for cancer and bariatric endpoints. Statistical analysis was performed using mixed effects regression models, generalized estimating equation, conditional logistic regression, and Fisher’s exact tests.
Women who developed breast cancer after bariatric surgery presented at an earlier stage compared to non-operated, obese controls. In the bariatric surgery group, there were fewer tumors with human epidermal growth factor receptor 2 overexpression (HER2+) (OR 0.16 (0.03–0.76); p = 0.02), with no significant differences seen in estrogen and progesterone receptor positivity. No HER2+ cancers were found in patients who underwent Roux-en-Y gastric bypass (OR 0.00 (0.00–0.43); p = 0.002). On multivariate analysis, bariatric surgery status remained associated with reduced HER2+ breast cancers (OR 0.18 (0.03–0.99); p < 0.05). At a mean follow-up of 5 years, bariatric surgery was associated with trends toward reduced cancer-specific and all-cause mortality.
Bariatric surgery is associated with reduced HER2+ breast cancers, suggesting that bariatric surgery can influence breast cancer characteristics and, potentially, tumor biology.
KeywordsBariatric surgery Breast cancer Roux-en-Y gastric bypass HER2 overexpression
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (London, England) [Internet]. 2008;371:569–78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18280327.
- 2.Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ [Internet]. 2007;335:1134. Available from: http://www.bmj.com/cgi/content/abstract/335/7630/1134%5Cn http://pubmedcentralcanada.ca/picrender.cgi?accid=PMC2099519&blobtype=pdf.
- 3.Samanic C, Chow W-H, Gridley G, et al. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer causes & control : CCC. 2006;17:901–9.Google Scholar
- 4.Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England J Med [Internet]. 2003;348:1625–38. https://doi.org/10.1056/NEJMoa021423.
- 5.Trentham-Dietz A, Nichols HB, Hampton JM, et al. Weight change and risk of endometrial cancer. Int J Epidemiol. 2006;35:151–8.Google Scholar
- 6.Tee MC, Cao Y, Warnock GL, et al. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg Endoscopy [Internet]. 2013;27:4449–56. https://doi.org/10.1007/s00464-013-3127-9.
- 7.U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute [Internet]. 2017; https://nccd.cdc.gov/uscs/. Available from: www.cdc.gov/uscs.
- 8.Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA [Internet]. 2006;296:193. https://doi.org/10.1001/jama.296.2.193.
- 9.National Heart Lung and Blood Institute, National Institutes of Health (NIH) National Heart, Lung, and Blood Institute N. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report, NIH Publication No. 98–4083. [Internet]. WMJ official publication of the State Medical Society of Wisconsin. 1998. Available from: https://hearttruth.gov/health/public/heart/obesity/wecan/portion/documents/CORESET1.pdf.
- 10.Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc. 2006;81:S46–51.Google Scholar
- 11.Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring, Md) [Internet]. 2009;17:796–802. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2859193&tool=pmcentrez&rendertype=abstract.
- 12.Sjöström L, Gummesson A, Sjöström CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish obese subjects study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10:653–62.Google Scholar
- 13.Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg [Internet]. 2017:1. Available from: http://insights.ovid.com/crossref?an=00000658-900000000-95889.
- 14.Haque R, Ahmed SA, Inzhakova G, et al. Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomarkers Prev. 2012;21:1848–55. Available from: http://cebp.aacrjournals.org/content/21/10/1848.abstract.
- 16.Gianni L, Pienkowski T, Im YH, et al. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial. Lancet Oncol. 2016;17:791–800.CrossRefPubMedGoogle Scholar
- 18.Lorincz AM, Sukumar SMolecular links between obesity and breast cancer. Endocrine-Related Cancer. 2006. p. 279–92.Google Scholar
- 20.Hursting SD, Digiovanni J, Dannenberg AJ, et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Philadelphia, Pa) [Internet]. 2012;5:1260–72. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3641761&tool=pmcentrez&rendertype=abstract.CrossRefGoogle Scholar
- 21.Gucalp A, Iyengar NM, Hudis CA, et al. Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression. Sem Oncol. 2016:154–60.Google Scholar
- 28.Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes [Internet]. 2005;54:2277–86. Available from: http://diabetes.diabetesjournals.org/content/54/8/2277.abstract?ijkey=58e36bbe2e7d0a5773784af2ecc7597351b62dbc&keytype2=tf_ipsecsha.CrossRefGoogle Scholar
- 29.Garland M, Hsu FC, Clark C, et al. The impact of obesity on outcomes for patients undergoing mastectomy using the ACS-NSQIP data set. Breast Cancer Res Treat. 2018:1–4.Google Scholar
- 30.Panayi A, Agha R, Sieber B, Orgill D. Impact of obesity on outcomes in breast reconstruction: a systematic review and meta-analysis. Journal of Reconstructive Microsurgery [Internet]. 2018; Available from: https://doi.org/10.1055/s-0038-1627449.